New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Ascend Wellness Holdings, Inc.
AAWH
Shape
US Flag

PNK

Unprofitable

Unprofitable

190M

Drug Manufacturers - Specialty & Generic

Next Earning date - 12 Nov 2024

190M

Drug Manufacturers - Specialty & Generic

Next Earning date - 12 Nov 2024

0.89USD
Shape0.02 ( 2.07%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-93%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

51%

Quote Panel

Shape
Updated October 24, 2024
1W 10.01 % 1M -1.13 % 3M -15.38 % 1Y 0.57 %

Key Metrics

Shape
  • Market Cap

    190.27M


  • Shares Outstanding

    214.27M


  • Share in Float

    144.74M


  • Dividende

    0


  • Earning Date

    12 Nov 2024


  • Price Target

    0.888


  • Average Volume

    159765


  • Beta

    2.293


  • Range

    0.71-1.82


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.awholdings.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.34x

P/S Ratio

1.63x

P/B Ratio

2.7

Debt/Equity

-12.5%

Net Margin

$-0.3

EPS

How AAWH compares to sector?

P/E Ratio

Relative Strength

Shape

AAWH

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$617M

Shape336%

2025-Revenue

$0.20

Shape-98%

2025-EPS

$64M

Shape-403%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Zacks Investment Research

upgrade

Previous: Not converted

2022-04-25

Now: Hold

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.09
vs -0.08

Q4.22

arrow
arrow

N/A

-0.08
vs -0.10

Q1.23

arrow
arrow

N/A

-0.10
vs -0.07

Q2.23

arrow
arrow

+105%

0
vs -0.09

Q3.23

arrow
arrow

N/A

-0.05
vs -0.09

Q4.23

arrow
arrow

N/A

-0.09
vs -0.08

Q1.24

arrow
arrow

N/A

-0.09
vs -0.10

Q2.24

arrow
arrow

N/A

-0.10
vs 0

Q3.24

arrow
arrow

N/A

-0.09
vs -0.05

Q4.24

arrow
arrow

N/A

-0.08
vs -0.09

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+18%

111.2M  vs 94.4M

Q4.22

arrow
arrow

+27%

112.1M  vs 88.5M

Q1.23

arrow
arrow

+34%

114.2M  vs 85.1M

Q2.23

arrow
arrow

+26%

123M  vs 97.5M

Q3.23

arrow
arrow

+27%

141.3M  vs 111.2M

Q4.23

arrow
arrow

+25%

140.2M  vs 112.1M

Q1.24

arrow
arrow

+25%

142.4M  vs 114.2M

Q2.24

arrow
arrow

+15%

141.5M  vs 123M

Q3.24

arrow
arrow

+2%

144.5M  vs 141.3M

Q4.24

arrow
arrow

+6%

149M  vs 140.2M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-10%

-0.10
vs -0.11

Q4.22

arrow
arrow

-9%

-0.09
vs -0.10

Q1.23

arrow
arrow

-12%

-0.12
vs -0.09

Q2.23

arrow
arrow

+1%

0.01
vs -0.12

Q3.23

arrow
arrow

-7%

-0.07
vs 0.01

Q4.23

arrow
arrow

-14%

-0.14
vs -0.07

Q1.24

arrow
arrow

-13%

-0.13
vs -0.14

Q2.24

arrow
arrow

-19%

-0.19
vs -0.13

Institutionnal OwnershipShape

status-upQoQ

Q4.21

arrow
arrow

1

1
vs NA

NA

Q1.22

arrow
arrow

2

2
vs 1

100%

Q2.22

arrow
arrow

2

2
vs 2

NA

Q3.22

arrow
arrow

1

1
vs 2

-50%

Q4.22

arrow
arrow

1

1
vs 1

NA

Q4.23

arrow
arrow

1

1
vs NA

NA

Q1.24

arrow
arrow

1

1
vs 1

NA

Q2.24

arrow
arrow

1

1
vs 1

NA

Earnings Growth

Latest News